Known targets — ChEMBL curated mechanism
GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHMGCRMMP1MMP13MMP7MMP8PTGS1PTGS2ileSpolrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA4 | P22748 | 2/20 | 0.31 |
| ▸ | CPT2 | P23786 | 1/20 | 0.31 |
| ▸ | CPT1A | P50416 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL2170087 | 0.98 | CA2 (0.31) | CA2CA4CPT2CPT1A | |
| SCHEMBL1389543 | 0.98 | CA2 (0.33) | CA2CA4CPT2CPT1A | |
| Water SCHEMBL11495893 | 0.97 | CA2 (0.32) | CA2CA4CPT2CPT1A | |
| SCHEMBL11099372 | 0.97 | CA2 (0.32) | CA2CA4CPT2CPT1A | |
| Water SCHEMBL976877 | 0.97 | CA2 (0.32) | CA2CA4CPT2CPT1A | |
| SCHEMBL7149875 | 0.97 | CA4 (0.35) | CA2CA4CPT2CPT1A | |
| Water SCHEMBL9243946 | 0.97 | CA2 (0.32) | CA2CA4CPT2CPT1A | |
| Water SCHEMBL8963366 | 0.95 | CA4 (0.34) | CA2CA4CPT2CPT1A | |
| Water SCHEMBL8030606 | 0.95 | CA4 (0.34) | CA2CA4CPT2CPT1A | |
| SCHEMBL11131358 | 0.95 | CPT2 (0.32) | CPT2CPT1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250033986-A1 | EXTRUSION-ENCAPSULATED CALCIUM SALTS AS OPACIFYING/WHITENING AGENTS | CAPOL INC. (CA) | 2025-01-30 | — | — | US | claimed |
| US-10653139-B2 | Device for stored products protection and uses thereof | UNIVERSIDADE DO PORTO (PT) | 2020-05-19 | — | — | US | claimed |
| US-20180310556-A1 | DEVICE FOR STORED PRODUCTS PROTECTION AND USES THEREOF | UNIVERSIDADE DO PORTO (PT) | 2018-11-01 | — | — | US | claimed |
| EP-3367793-A1 | DEVICE FOR STORED PRODUCTS PROTECTION AND USES THEREOF | Universidade do Porto (PT) | 2018-09-05 | — | — | EP | claimed |
| WO-2017072563-A1 | DEVICE FOR STORED PRODUCTS PROTECTION AND USES THEREOF | UNIVERSIDADE DO PORTO (PT) | 2017-05-04 | — | — | WO | claimed |
| EP-3107408-A1 | ENCAPSULATED SOFT FOOD COMPOSITIONS AND METHODS OF MAKING | Incredible Foods, Inc. (US) | 2016-12-28 | — | — | EP | claimed |
| WO-2015127063-A1 | ENCAPSULATED SOFT FOOD COMPOSITIONS AND METHODS OF MAKING | WIKIFOODS, INC. (US) | 2015-08-27 | — | — | WO | claimed |
| JP-4173098-A | — | — | None | — | — | JP | disclosed |
| US-20260110140-A1 | PACKAGING ITEM | NOTPLA LTD (GB) | 2026-04-23 | — | — | US | disclosed |
| US-12485091-B2 | Controlled release core-shell particles and suspensions including the same | Nulixir Inc. (US) | 2025-12-02 | — | — | US | disclosed |
| US-20250302823-A1 | COMPOSITIONS AND METHODS FOR TREATING HEPATIC PORPHYRIAS WITH GLYCINE TRANSPORT INHIBITORS | DISC MEDICINE, INC. | 2025-10-02 | — | — | US | disclosed |
| US-12350367-B2 | Particles for administration of active ingredients and methods of making the same | Nulixir Inc. (US) | 2025-07-08 | — | — | US | disclosed |
| EP-4531854-A1 | COMPOSITIONS AND METHODS FOR TREATING HEPATIC PORPHYRIAS WITH GLYCINE TRANSPORT INHIBITORS | Disc Medicine, Inc. (US) | 2025-04-09 | — | — | EP | disclosed |
| WO-2006041469-A1 | PRESERVATIVE SYSTEMS FOR EXTENDING SHELF LIFE OF FOOD INTERMEDIATES THROUGH MICROBIAL AND ENZYMATIC CONTROL IN N0N-MODIFIED ATMOSPHERE | GENERAL MILLS MARKETING, INC. (US) | 2006-04-20 | — | — | WO | disclosed |
| US-5641533-A | SEMI-GELLED SYSTEM CONTAINING ATLEAST ONE LOW METHOXYPECTIN WITH SPECIFIC DEGREE OF ESTERIFICATION AND AMIDATION TO REPLACE ALL OR A PART OF FAT IN MAYONNAISE | HERCULES INCORPORATED (US) | 1997-06-24 | — | — | US | disclosed |
| US-5626901-A | DIETETICS USING AMIDATED GALACTURONIC ACID METHYL ESTER IN WATER FOR FAT REPLACEMENTS | HERCULES INCORPORATED (US) | 1997-05-06 | — | — | US | disclosed |
| EP-0758531-A2 | No and low fat majonnaise compositions | HERCULES INCORPORATED (US) | 1997-02-19 | — | — | EP | disclosed |
| EP-0757895-A2 | No and low fat salad dressing compositions | HERCULES INCORPORATED (US) | 1997-02-12 | — | — | EP | disclosed |
| JP-H04173098-A | PREVENTION OF COLOR DEVELOPMENT OF COLOR REAGENT FOR PEROXIDASE DURING STORAGE AND COLOR REAGENT FOR PEROXIDASE UTILIZING THE SAME METHOD | FUNAYAMA MASASHI | 1992-06-19 | — | — | JP | disclosed |
| US-4425367-A | MICROCRYSTALLINE CELLULOSE, SHELF LIFE | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1984-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250302823-A1 | COMPOSITIONS AND METHODS FOR TREATING HEPATIC PORPHYRIAS WITH GLYCINE TRANSPORT INHIBITORS | SLC10A1, GFPT1, GLS2 | CA2 531/4885CA4 1124/4885CPT2 550/4885 |
| US-20260110140-A1 | PACKAGING ITEM | AGL, PWWP2B, GHDC | CA2 4650/4885CA4 4374/4885CPT2 2007/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.